$COLL 8-K SEC Filings

Filed On	Filing
19 Oct 2026	8-K: Termination of a Material Definitive Agreement As previously disclosed, Collegium Pharmaceutical, Inc. (the “Company”) is party to a License Agreement (U.S.), dated as of January 13, 2015, with Grünenthal GmbH (“Grünenthal”) (as amended, the “Grünenthal License”) which the Company as...
13 Aug 2026	8-K: Other Events
06 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
15 May 2026	8-K: Submission of Matters to a Vote of Security Holders
12 May 2026	8-K: Completion of Acquisition or Disposition of Assets; Departure/Election of Directors or Officers; Compensation +1 more
07 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
07 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
19 Mar 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
26 Feb 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
08 Jan 2026	8-K: Regulation FD Disclosure
30 Dec 2025	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +2 more
06 Nov 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
07 Aug 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
07 Jul 2025	8-K: Other Events
19 May 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
12 May 2025	8-K: Other Events
08 May 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
17 Mar 2025	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
27 Feb 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
05 Feb 2025	8-K: Departure/Election of Directors or Officers; Compensation

Comments